# Minocycline Augmentation to Clozapine

> **NCT02124811** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 10 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT02124811
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02124811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02124811, "Minocycline Augmentation to Clozapine". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02124811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*